CAMBRIDGE, Mass., Aug. 7, 2024 /PRNewswire/ — LabCentral, the premier Massachusetts-based network of coworking labs designed to accelerate high-potential biotech startups, launched a new video series – “The Dish with Johannes.” In each episode, Johannes Fruehauf, MD, PhD, LabCentral’s co-founder and president, interviews biotech entrepreneurs and scientists who share the stories behind the startups at the heart of Massachusetts’ vibrant biotech culture.
Offering a front row seat to the business decisions and scientific innovations that have defined their careers and companies, each episode provides insights from the leaders shaping the industry’s dynamic future. New episodes will be available monthly, with the current schedule including:
To be alerted when new videos in the series are posted each month, subscribe or follow across the LabCentral channels:
About LabCentral
A private, non-profit institution, LabCentral is a launchpad for high potential life-sciences and biotech startups with 243,000 square feet of space across Kendall Square in Cambridge, Mass., and the Harvard University campus. Founded in 2013, LabCentral offers a full complement of programming and networking to life sciences entrepreneurs in addition to fully permitted laboratory and office space for early-stage and growing life sciences companies. More information is available at www.labcentral.org.
SOURCE LabCentral
HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia…
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused…
This generous grant will directly benefit the NCCS's Beyond the Cure Ambassador Scholarship Program, which…
Medical Co-working space challenges broken healthcare system. HOUSTON, TEXAS / ACCESSWIRE / December 23, 2024…
SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce"…
MIAMI, FL / ACCESSWIRE / December 23, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or the…